(Q33435967)

English

Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.

scientific article

Statements

Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial. (English)
1 reference
Padmanee Sharma
1 reference
Margaret K Callahan
1 reference
Petri Bono
1 reference
Joseph Kim
1 reference
Pavlina Spiliopoulou
1 reference
Emiliano Calvo
1 reference
Rathi N Pillai
1 reference
Patrick A Ott
1 reference
Michael Morse
1 reference
Dung T Le
1 reference
Dirk Jaeger
1 reference
Emily Chan
1 reference
Chris Harbison
1 reference
Chen-Sheng Lin
1 reference
Marina Tschaika
1 reference
Alex Azrilevich
1 reference
Jonathan E Rosenberg
1 reference
9 October 2016
1 reference
17
1 reference
1590-1598
1 reference
11
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit